Literature DB >> 7517562

The Fanconi anemia polypeptide FACC is localized to the cytoplasm.

T Yamashita1, D L Barber, Y Zhu, N Wu, A D D'Andrea.   

Abstract

Fanconi anemia (FA) is an autosomal recessive disease characterized by congenital anomalies, aplastic anemia, and chromosomal instability. A cDNA encoding the FA complementation group C (FACC) polypeptide was recently cloned [Strathdee, C. A., Gavish, H., Shannon, W. R. & Buchwald, M. (1992) Nature (London) 356, 763-767]. To further characterize this polypeptide, we generated a rabbit polyclonal antiserum against its carboxyl terminus. We used this antiserum to analyze the FACC polypeptide from normal or mutant (FA) lymphoblast cell lines. By immunoprecipitation, the wild-type FACC was a 60-kDa protein, consistent with its predicted molecular mass. FA group C cell lines expressed full-length FACC, truncated FACC, or no detectable FACC polypeptide. In addition, the antiserum specifically immunoprecipitated a 50-kDa and a 150-kDa FACC-related protein (FRP-50 and FRP-150). Unexpectedly, cell fractionation and immunofluorescence studies demonstrated that the FACC polypeptide localizes to the cytoplasm. In conclusion, we have generated an antiserum specific for the human FACC polypeptide. The antiserum should be useful for screening FA cells for mutant FACC polypeptides and for identifying and cloning FACC-related proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7517562      PMCID: PMC44273          DOI: 10.1073/pnas.91.14.6712

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Fanconi anemia mutation causes cellular susceptibility to ambient oxygen.

Authors:  D Schindler; H Hoehn
Journal:  Am J Hum Genet       Date:  1988-10       Impact factor: 11.025

2.  A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents.

Authors:  M S Sasaki; A Tonomura
Journal:  Cancer Res       Date:  1973-08       Impact factor: 12.701

3.  Abnormal NAD+ levels in cells from patients with Fanconi's anaemia.

Authors:  N A Berger; S J Berger; D M Catino
Journal:  Nature       Date:  1982-09-16       Impact factor: 49.962

4.  Defective repair of mitomycin C crosslinks in Fanconi's anemia and loss in confluent normal human and xeroderma pigmentosum cells.

Authors:  Y Fujiwara
Journal:  Biochim Biophys Acta       Date:  1982-12-31

5.  Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics.

Authors:  C A Pritsos; A C Sartorelli
Journal:  Cancer Res       Date:  1986-07       Impact factor: 12.701

6.  Antioxidant status of Fanconi anemia fibroblasts.

Authors:  J J Gille; H M Wortelboer; H Joenje
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

7.  Specific interaction between the p53 cellular tumour antigen and major heat shock proteins.

Authors:  O Pinhasi-Kimhi; D Michalovitz; A Ben-Zeev; M Oren
Journal:  Nature       Date:  1986 Mar 13-19       Impact factor: 49.962

8.  Mutation analysis of the Fanconi anemia gene FACC.

Authors:  P C Verlander; J D Lin; M U Udono; Q Zhang; R A Gibson; C G Mathew; A D Auerbach
Journal:  Am J Hum Genet       Date:  1994-04       Impact factor: 11.025

9.  Effect of oxidants and antioxidants on chromosomal breakage in Fanconi anemia lymphocytes.

Authors:  B Dallapiccola; B Porfirio; V Mokini; G Alimena; G Isacchi; E Gandini
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

10.  DNA repair dependent NAD+ metabolism is impaired in cells from patients with Fanconi's anemia.

Authors:  H Klocker; B Auer; M Hirsch-Kauffmann; H Altmann; H J Burtscher; M Schweiger
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  23 in total

1.  FANCE: the link between Fanconi anaemia complex assembly and activity.

Authors:  Paul Pace; Mark Johnson; Wu Meng Tan; Georgina Mosedale; Chelvin Sng; Maureen Hoatlin; Johan de Winter; Hans Joenje; Fanni Gergely; K J Patel
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

2.  Subtyping analysis of Fanconi anemia by immunoblotting and retroviral gene transfer.

Authors:  M Pulsipher; G M Kupfer; D Naf; A Suliman; J S Lee; P Jakobs; M Grompe; H Joenje; C Sieff; E Guinan; R Mulligan; A D D'Andrea
Journal:  Mol Med       Date:  1998-07       Impact factor: 6.354

3.  MxA overexpression reveals a common genetic link in four Fanconi anemia complementation groups.

Authors:  Y Li; H Youssoufian
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

4.  Prototype sequence clues within the Fanconi anaemia group C gene.

Authors:  W Liebetrau; M Bühner; H Hoehn
Journal:  J Med Genet       Date:  1995-08       Impact factor: 6.318

5.  Cytoplasmic localization of FAC is essential for the correction of a prerepair defect in Fanconi anemia group C cells.

Authors:  H Youssoufian
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

6.  DUB-1, a deubiquitinating enzyme with growth-suppressing activity.

Authors:  Y Zhu; M Carroll; F R Papa; M Hochstrasser; A D D'Andrea
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

7.  Fanconi anaemia complementation groups in Germany and The Netherlands. European Fanconi Anaemia Research group.

Authors:  H Joenje
Journal:  Hum Genet       Date:  1996-03       Impact factor: 4.132

8.  Interstrand cross-links induce DNA synthesis in damaged and undamaged plasmids in mammalian cell extracts.

Authors:  L Li; C A Peterson; X Lu; P Wei; R J Legerski
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

9.  The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors.

Authors:  Q Pang; S Fagerlie; T A Christianson; W Keeble; G Faulkner; J Diaz; R K Rathbun; G C Bagby
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

10.  The fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation.

Authors:  T Yamashita; G M Kupfer; D Naf; A Suliman; H Joenje; S Asano; A D D'Andrea
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.